Andrew Williams1, Katherine Grantz1, Indulaxmi Seeni1, Candace Robledo2, Shanshan Li3, Marion Ouidir1, Carrie Nobles1, Pauline Mendola4. 1. Epidemiology Branch, Division of Intramural Population Health Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, Bethesda, MD, USA. 2. Department of Population Health and Biostatistics, University of Texas Rio Grande Valley School of Medicine, Harlingen, TX, USA. 3. Slone Epidemiology Center, Boston University School of Medicine, Boston, MA, USA. 4. Epidemiology Branch, Division of Intramural Population Health Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, Bethesda, MD, USA. Electronic address: pauline.mendola@nih.gov.
Abstract
BACKGROUND: The impact of autoimmune diseases on pregnancy remains understudied on a population level. Examination of obstetric and neonatal outcomes among women with autoimmune disease and their infants can provide important insights for clinical management. METHODS: Autoimmune diseases and outcomes were identified using medical records. Cesarean delivery, preterm birth, preeclampsia, small for gestational age (SGA), neonatal intensive care (NICU) admission, neonatal respiratory distress syndrome (RDS), and perinatal mortality risk was assessed. Poisson regression with robust standard errors estimated relative risks (RR) and 95% confidence intervals (95% CI) with adjustment for maternal characteristics and other chronic conditions. RESULTS: Women with T1DM were at increased risk for nearly all outcomes including RDS (RR: 3.62; 95% CI: 2.84, 4.62), perinatal mortality (RR: 2.35; 95% CI: 1.12, 4.91), cesarean delivery (RR: 2.16; 95% CI: 2.02, 2.32) and preterm birth (RR: 3.52; 95% CI: 3.17, 3.91). Women with SLE also had higher risk for preterm delivery (RR: 2.90; 95% CI: 2.42, 3.48) and RDS (RR:2.99; 95% CI: 1.99, 4.51) as did women with Crohn's (cesarean delivery RR:1.31, 95% CI: 1.08, 1.60; preterm delivery RR: 1.84, 95% CI: 1.37, 2.49. RA increased risk for SGA (RR:1.66; 95% CI: 1.08, 2.55). CONCLUSION(S): Despite the heterogeneity in autoimmune diseases, we observed elevated preterm birth risk for most women with autoimmune disease. SLE and T1DM appeared to confer increased risk for a wide range of adverse outcomes. Published by Elsevier Ltd.
BACKGROUND: The impact of autoimmune diseases on pregnancy remains understudied on a population level. Examination of obstetric and neonatal outcomes among women with autoimmune disease and their infants can provide important insights for clinical management. METHODS:Autoimmune diseases and outcomes were identified using medical records. Cesarean delivery, preterm birth, preeclampsia, small for gestational age (SGA), neonatal intensive care (NICU) admission, neonatal respiratory distress syndrome (RDS), and perinatal mortality risk was assessed. Poisson regression with robust standard errors estimated relative risks (RR) and 95% confidence intervals (95% CI) with adjustment for maternal characteristics and other chronic conditions. RESULTS:Women with T1DM were at increased risk for nearly all outcomes including RDS (RR: 3.62; 95% CI: 2.84, 4.62), perinatal mortality (RR: 2.35; 95% CI: 1.12, 4.91), cesarean delivery (RR: 2.16; 95% CI: 2.02, 2.32) and preterm birth (RR: 3.52; 95% CI: 3.17, 3.91). Women with SLE also had higher risk for preterm delivery (RR: 2.90; 95% CI: 2.42, 3.48) and RDS (RR:2.99; 95% CI: 1.99, 4.51) as did women with Crohn's (cesarean delivery RR:1.31, 95% CI: 1.08, 1.60; preterm delivery RR: 1.84, 95% CI: 1.37, 2.49. RA increased risk for SGA (RR:1.66; 95% CI: 1.08, 2.55). CONCLUSION(S): Despite the heterogeneity in autoimmune diseases, we observed elevated preterm birth risk for most women with autoimmune disease. SLE and T1DM appeared to confer increased risk for a wide range of adverse outcomes. Published by Elsevier Ltd.
Authors: Shagufta Yasmeen; Patrick S Romano; Michael E Schembri; Janet M Keyzer; William M Gilbert Journal: Am J Obstet Gynecol Date: 2006-04 Impact factor: 8.661
Authors: Meghan Angley; Carolyn Drews-Botsch; Tené T Lewis; Martina Badell; S Sam Lim; Penelope P Howards Journal: Arthritis Care Res (Hoboken) Date: 2022-04-05 Impact factor: 5.178
Authors: Jacqueline R Lim; Timothy C Nielsen; Russell C Dale; Hannah F Jones; Amanda Beech; Natasha Nassar; Samantha J Lain; Antonia Shand Journal: Obstet Med Date: 2020-11-03
Authors: Andrew D Williams; Jenna Kanner; Katherine L Grantz; Marion Ouidir; Shanshan Sheehy; Seth Sherman; Candace Robledo; Pauline Mendola Journal: Environ Res Date: 2021-04-18 Impact factor: 8.431
Authors: April Barnado; Amanda M Eudy; Ashley Blaske; Lee Wheless; Katie Kirchoff; Jim C Oates; Megan E B Clowse Journal: Arthritis Care Res (Hoboken) Date: 2022-03-16 Impact factor: 5.178
Authors: Laura Köcher; Marios Rossides; Katarina Remaeus; Johan Grunewald; Anders Eklund; Susanna Kullberg; Elizabeth V Arkema Journal: Respir Res Date: 2020-08-27